Abstracts tagged "osteoarthritis and severity"

Abstract Number: 2003 • 2018 ACR/ARHP Annual Meeting
Chondrocyte Size in Articular Cartilage As a Marker of Osteoarthritis Severity
Paula Gratal¹, Aranzazu Mediero², Iván Prieto-Potin¹, Ana Lamuedra¹, Gabriel Herrero-Beaumont¹ and Raquel Largo¹, ¹Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain, ²Joint and Bone Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain
Background/Purpose: Terminal differentiating growth plate chondrocytes are mainly characterized by an increase of their cell size and by the expression of hypertrophic markers such as…
Abstract Number: 2182 • 2016 ACR/ARHP Annual Meeting
Levels of Severity of Hip and Knee OA – Validation of Lay Descriptions
Marita Cross¹, Willy Ngueyon Sime², Francis Guillemin² and Lyn March³, ¹Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW, Australia, ²University of Lorraine, Nancy, France, ³Department of Rheumatology, Northern Clinical School, Institute of Bone and Joint Research, Kolling Institute, University of Sydney & Department of Rheumatology, Royal North Shore Hospital, St Leonards, Sydney, Australia
Background/Purpose: Estimating the proportion of the population with severe OA is useful for health service planning. To calculate the proportion of the population with mild,…
Abstract Number: 1133 • 2012 ACR/ARHP Annual Meeting
Gait Differences Are Present in Subjects with Symptomatic Vs. Asymptomatic Mild Radiographic Hip Osteoarthritis
Samir S. Chabra¹, Najia Shakoor² and Kharma C. Foucher³, ¹Bioengineering, University of Illinois at Chicago, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Orthopedic Surgery, Rush University Medical Center, Chicago, IL
Background/Purpose: It is known that joint mechanics are involved in the hip osteoarthritis (OA) disease process. In a previous study1, several gait variables were lower…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].